TICKERNOMICS Sign up
Last Update: 2024-03-28 02:16:44
Spectral Med Inc ( EDT.TO ) https://www.spectraldx.com
0.34USD
Sector:
Healthcare
Industry:
Diagnostics & Research
Country:
Canada
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
EDT.TO
54.52%
SPY
32.74%
-16.64%
EDT.TO
SPY
92.93%
EDT.TO
20.92%
SPY
224.41%
EDT.TO
25.03%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
81.91
87.28
0.04
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-9.68
63.26
-10.90
-12.66
0.00
-11.26
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-630.98
23.17
-637.65
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.7762
-147.58
-150.67
0.94
Other Earnings and Cash Flow Stats:
Spectral Med Inc ( EDT.TO ) Net Income TTM ($MM) is -8.01
Spectral Med Inc ( EDT.TO ) Operating Income TTM ($MM) is -6.10
Spectral Med Inc ( EDT.TO ) Owners' Earnings Annual ($MM) is -11.16
Spectral Med Inc ( EDT.TO ) Current Price to Owners' Earnings ratio is -8.44
Spectral Med Inc ( EDT.TO ) EBITDA TTM ($MM) is -5.93
Spectral Med Inc ( EDT.TO ) EBITDA Margin is -637.65%
Capital Allocation:
Spectral Med Inc ( EDT.TO ) has paid 0.00 dividends per share and bought back -8.732814 million shares in the past 12 months
Spectral Med Inc ( EDT.TO ) has increased its debt by 4.1175744743518 million USD in the last 12 months
Capital Structure:
Spectral Med Inc ( EDT.TO ) Interest-bearing Debt ($MM) as of last quarter is 9
Spectral Med Inc ( EDT.TO ) Annual Working Capital Investments ($MM) are 0
Spectral Med Inc ( EDT.TO ) Book Value ($MM) as of last quarter is -8
Spectral Med Inc ( EDT.TO ) Debt/Capital as of last quarter is -122%
Other Balance Sheet Stats:
Spectral Med Inc ( EDT.TO ) has 3 million in cash on hand as of last quarter
Spectral Med Inc ( EDT.TO ) has 2 million of liabilities due within 12 months, and long term debt 8 as of last quarter
Spectral Med Inc ( EDT.TO ) has 278 common shares outstanding as of last quarter
Spectral Med Inc ( EDT.TO ) has 0 million USD of preferred stock value
Academic Scores:
Spectral Med Inc ( EDT.TO ) Altman Z-Score is -18.93 as of last quarter
Spectral Med Inc ( EDT.TO ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Spectral Med Inc ( EDT.TO ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of Spectral Med Inc ( EDT.TO ) for the amount of $ on
15.19% of Spectral Med Inc ( EDT.TO ) is held by insiders, and 9.76% is held by institutions
Spectral Med Inc ( EDT.TO ) went public on 1970-01-01
Other Spectral Med Inc ( EDT.TO ) financial metrics:
FCF:-8.57
Unlevered Free Cash Flow:-8.03
EPS:-0.04
Operating Margin:-630.98
Gross Profit Margin:23.17
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:136.05
Beta:0.94
Buffet's Owners Earnings:-11.16
Price to Owner's Earnings:-8.44
About Spectral Med Inc ( EDT.TO ) :
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.